Global Dermatology Devices Market Growth Outlook 2030 | DelveInsight

DelveInsight's Connected Drug Delivery Devices Market Insights Report 2030 provides the current and forecast market analysis, individual leading companies' market shares, challenges, Market Drivers, barriers, trends, and key Connected Drug Delivery Devices Companies in the market.

To read more about the latest highlights related to the Connected Drug Delivery Devices Market, get a snapshot of the key highlights entailed in the Market Report @ Connected Drug Delivery Devices Market Size- https://www.delveinsight.com/sample-request/connected-drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Connected Drug Delivery Devices Market Report
• Globally connected drug delivery devices market is estimated to grow at a CAGR of 23.59% during the forecast period from 2024 to 2030.
• Among all the regions, North America is estimated to account for the largest share of the connected drug delivery devices market in the year 2023.
• The leading Connected Drug Delivery Devices Companies such as Findair Sp. z o. o., Adherium, Propeller Health., West Pharmaceutical Services, Inc., BIOCORP, Phillips-Medisize, Merck KGaA, Novo Nordisk A/S, Medtronic, Tandem Diabetes Care, Inc., Ypsomed, Teva Pharmaceutical Industries Ltd., Elcam Medical, Cohero Health, Inc., BD., and others.

To know more about why North America is leading the market growth in the Connected Drug Delivery Devices Market, get a snapshot @ Connected Drug Delivery Devices Market Outlook- https://www.delveinsight.com/sample-request/connected-drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Connected Drug Delivery Devices Market Dynamics
The International Diabetes Federation (IDF) Diabetes Atlas Tenth edition 2021 provided the latest figures, which stated that in 2023, approximately 537 million adults (20-79 years) were living with diabetes, globally. Also, the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. The same source stated that more than 1.2 million children and adolescents (0-19 years) across the globe were living with type 1 diabetes, in 2021 and nearly 541 million adults were at increased risk of developing type 2 diabetes. The increasing prevalence of diabetes will increase the demand for insulin patches, pens, infusion pumps, and others; which are a type of connected drug delivery device ultimately driving the overall market growth.

Connected Drug Delivery Devices Market Segment Analysis
Connected Drug Delivery Devices Market by Product (Connected Sensors [Connected Inhaler Sensors and Connectable Injection Sensors] and Integrated Connected Devices [Connected Inhaler Devices and Connected Injection Devices], Technology (Bluetooth, Near-Field Communication (NFC), and Others), End-User (Healthcare Providers and Homecare), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

To know more about why North America is leading the market growth in the Connected Drug Delivery Devices Market, get a snapshot @ Connected Drug Delivery Devices Market Insights- https://www.delveinsight.com/sample-request/connected-drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Connected Drug Delivery Devices Companies
Findair Sp. z o. o., Adherium, Propeller Health., West Pharmaceutical Services, Inc., BIOCORP, Phillips-Medisize, Merck KGaA, Novo Nordisk A/S, Medtronic, Tandem Diabetes Care, Inc., Ypsomed, Teva Pharmaceutical Industries Ltd., Elcam Medical, Cohero Health, Inc., BD., and others.

Connect Drug Delivery Devices Market Drivers
The rising incidence of chronic diseases and the rising number of geriatric patients who are susceptible to chronic illnesses are what are driving up demand for linked drug delivery devices. During the forecast period of 2024-2030, additional factors such as growing patient connectivity and engagement, rising product launches and approvals, and innovation in product development will also contribute to the overall growth of the connected drug delivery devices market.

Connected Drug Delivery Devices Market Growth
The increasing prevalence of diabetes will increase the demand for insulin patches, pens, infusion pumps, and others; which are a type of connected drug delivery device ultimately driving the overall market growth. The rising awareness about adherence to prescribed therapies and self-administration of drugs and innovation in product development among others are thereby contributing to the overall growth of the connected drug delivery devices market during the forecast period from 2024-2030. Another important factor driving the market growth is the rising need to improve patient medication adherence. As more patients use connected drug delivery devices, they will be able to manage their treatment more efficiently by reducing the number of visits to clinics and hospitals. Connected devices aid in proper dosage and administration, resulting in a successful treatment without the need for costly secondary interventions. These systems also include reminders and adherence trackers, which make it easier for patients to stick to their medication regimen.

Which MedTech key players in the Connected Drug Delivery Devices Market are set to emerge as the trendsetter explore @ Connected Drug Delivery Devices Companies- https://www.delveinsight.com/sample-request/connected-drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Connected Drug Delivery Devices Market Report
• Coverage- Global
• Forecast Period- 2024-2030
• Connected Drug Delivery Devices Companies- Findair Sp. z o. o., Adherium, Propeller Health., West Pharmaceutical Services, Inc., BIOCORP, Phillips-Medisize, Merck KGaA, Novo Nordisk A/S, Medtronic, Tandem Diabetes Care, Inc., Ypsomed, Teva Pharmaceutical Industries Ltd., Elcam Medical, Cohero Health, Inc., BD., and others.

Interested in knowing the Connected Drug Delivery Devices Market by 2030? Click to get a snapshot of the Connected Drug Delivery Devices Market Trends- https://www.delveinsight.com/sample-request/connected-drug-delivery-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.